Cook Medical has announced that its Zenith iliac branch device (ZBIS) is now commercially available in the U.S. with Food and Drug Administration (FDA) approval as an endovascular treatment option for aortoiliac or iliac aneurysmal disease.
The company has also shared that first implantations of the ZBIS were performed at several centers in the U.S.
According to Cook, the ZBIS—when used with the necessary additional components (Zenith AAA and a covered bridging stent)—is indicated for the endovascular treatment of patients with an aortoiliac or iliac aneurysm to preserve internal iliac arterial blood flow when the distal sealing site in the common iliac artery is insufficient for the abdominal aortic aneurysm (AAA) device alone and when the vessel morphology is suitable for repair.
